Circulation Reports
Online ISSN : 2434-0790
Metabolism
Evidence for Urate Uptake Through Monocarboxylate Transporter 9 Expressed in Mammalian Cells and Its Enhancement by Heat Shock
Naoyuki OtaniYasutaka KurataNani MaharaniMasanari KuwabaraNobuhito IkedaTomomi NotsuPeili LiJunichiro MiakeAkio YoshidaHiromi SakaguchiKatsumi HigakiNaoe NakasoneMotokazu TsunetoYasuaki ShirayoshiMotoshi OuchiHaruaki NinomiyaKazuhiro YamamotoNaohiko AnzaiIchiro Hisatome
Author information
JOURNALS OPEN ACCESS FULL-TEXT HTML
Supplementary material

2020 Volume 2 Issue 8 Pages 425-432

Details
Abstract

Background:Monocarboxylate transporter 9 (MCT9), an orphan transporter member of the solute carrier family 16 (SLC16), possibly reabsorbs uric acid in the renal tubule and has been suggested by genome-wide association studies to be involved in the development of hyperuricemia and gout. In this study we investigated the mechanisms regulating the expression of human (h) MCT9, its degradation, and physiological functions.

Methods and Results:hMCT9-FLAG was stably expressed in HEK293 cells and its degradation, intracellular localization, and urate uptake activities were assessed by pulse-chase analysis, immunofluorescence, and [14C]-urate uptake experiments, respectively. hMCT9-FLAG was localized on the plasma membrane as well as in the endoplasmic reticulum and Golgi apparatus. The proteasome inhibitors MG132 and lactacystine increased levels of hMCT9-FLAG protein expression with enhanced ubiquitination, prolonged their half-life, and decreased [14C]-urate uptake. [14C]-urate uptake was increased by both heat shock (HS) and the HS protein inducer geranylgeranylacetone (GGA). Both HS and GGA restored the [14C]-urate uptake impaired by MG132.

Conclusions:hMCT9 does transport urate and is degraded by a proteasome, inhibition of which reduces hMCT9 expression on the cell membrane and urate uptake. HS enhanced urate uptake through hMCT9.

Information related to the author
© 2020 THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top